Characterization of the translation-dependent step during iron-regulated decay of transferrin receptor mRNA

Citation
M. Posch et al., Characterization of the translation-dependent step during iron-regulated decay of transferrin receptor mRNA, J BIOL CHEM, 274(23), 1999, pp. 16611-16618
Citations number
83
Categorie Soggetti
Biochemistry & Biophysics
Journal title
JOURNAL OF BIOLOGICAL CHEMISTRY
ISSN journal
00219258 → ACNP
Volume
274
Issue
23
Year of publication
1999
Pages
16611 - 16618
Database
ISI
SICI code
0021-9258(19990604)274:23<16611:COTTSD>2.0.ZU;2-Q
Abstract
Iron regulates the stability of the mRNA encoding the transferrin receptor (TfR). When iron is scarce, iron regulatory proteins (IRPs) stabilize TfR m RNA by binding to the 3'-untranslated region. High levels of iron induce de gradation of TfR mRNA; the translation inhibitor cycloheximide prevents thi s. To distinguish between cotranslational mRNA decay and a trans effect of translation inhibitors, we designed a reporter system exploiting the proper ties of the selectable marker gene thymidine kinase (TK), The 3'-untranslat ed region of human transferrin receptor, which contains all elements necess ary for iron-dependent regulation of mRNA stability, was fused to the TK cD NA. In stably transfected mouse fibroblasts, the expression of the reporter gene was perfectly regulated by iron. Introduction of stop codons in the T K coding sequence or insertion of stable stem-loop structures in the leader sequence did not affect on the iron-dependent regulation of the reporter m RNA This implies that global translation inhibitors stabilize TfR mRNA in t rans. Cycloheximide prevented the destabilization of TfR mRNA only in the p resence of active IRPs. Inhibition of IRP inactivation by cycloheximide or by the specific proteasome inhibitor MG132 correlated with the stabilizatio n of TfR mRNA These observations suggest that inhibition of translation by cycloheximide interferes with the rate-limiting step of iron-induced TfR mR NA decay in a transacting mechanism by blocking IRP inactivation.